ACHIEVE LIFE SCIENCES, INC. (ACHV)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Gross Profit TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Net Income TTM

-120M -80M -40M 0 40M 80M 120M Q4 '10: -12.6M Q1 '11: -12.6M Q2 '11: -6.2M Q3 '11: -3.8M Q4 '11: -10.6M Q1 '12: -14.4M Q2 '12: -25.1M Q3 '12: -26.6M Q4 '12: -21.1M Q1 '13: -20.9M Q2 '13: -25.1M Q3 '13: -29.3M Q4 '13: -31.8M Q1 '14: -33.8M Q2 '14: -32.4M Q3 '14: -27.2M Q2 '15: -21.1M Q3 '15: -20.8M Q4 '15: -16.8M Q1 '16: -16M Q2 '16: -16.9M Q3 '16: -12.6M Q4 '16: -11.3M Q1 '17: -7.8M Q2 '17: -1.1M Q3 '17: -7.3M Q4 '17: -10.6M Q1 '18: -13.4M Q2 '18: -16M Q3 '18: -12.8M Q4 '18: -12.7M Q1 '19: -15.6M Q2 '19: -16.4M Q3 '19: -16.8M Q4 '19: -16.4M Q1 '20: -13.8M Q2 '20: -13.1M Q3 '20: -13.2M Q4 '20: -14.7M Q1 '21: -19.4M Q2 '21: -27.8M Q3 '21: -30.7M Q4 '21: -33.2M Q1 '22: -32.7M Q2 '22: -31.9M Q3 '22: -38.3M Q4 '22: -42.4M Q1 '23: -43.8M Q2 '23: -41.5M Q3 '23: -35.6M Q4 '23: -29.8M Q1 '24: -27.3M Q2 '24: -27.5M Q3 '24: -32.9M Q4 '24: -39.8M Q1 '25: -46.2M Q2 '25: -50.4M Q3 '25: -52.3M Q4 '25: -54.6M Q1 '26: -52M Q2 '26: -114M Q4 '11 Q4 '13 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Cost of Revenue TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow TTM

-60M -40M -20M 0 20M 40M 60M Q2 '11: -18.7M Q3 '11: -19.5M Q4 '11: -20.3M Q1 '12: -23.6M Q2 '12: -31.7M Q3 '12: -38.4M Q4 '12: -43.5M Q1 '13: -46.8M Q2 '13: -40.6M Q3 '13: -37.9M Q4 '13: -35.9M Q1 '14: -26.9M Q2 '14: -22.4M Q3 '14: -17.9M Q4 '14: -17.3M Q1 '15: -22.1M Q2 '15: -2.5M Q3 '15: -5.4M Q4 '15: -350K Q1 '16: -3M Q2 '16: -26M Q3 '16: -2.1M Q4 '16: -202K Q1 '17: 8.9M Q2 '17: 3.7M Q3 '17: -17M Q4 '17: -20.6M Q1 '18: -22.8M Q2 '18: -13.2M Q3 '18: -10.7M Q4 '18: -10.6M Q1 '19: -13.3M Q2 '19: -15.3M Q3 '19: -15.3M Q4 '19: -15.2M Q1 '20: -14.8M Q2 '20: -13.1M Q3 '20: -14.4M Q4 '20: -13.5M Q1 '21: -15.5M Q2 '21: -22.3M Q3 '21: -26.7M Q4 '21: -29.4M Q1 '22: -29.8M Q2 '22: -29M Q3 '22: -31.6M Q4 '22: -37.6M Q1 '23: -39.1M Q2 '23: -37.4M Q3 '23: -31.3M Q4 '23: -24.5M Q1 '24: -21.5M Q2 '24: -19.7M Q3 '24: -24.9M Q4 '24: -29.8M Q1 '25: -35.6M Q2 '25: -39.7M Q3 '25: -40.7M Q4 '25: -49.5M Q1 '26: -45.3M Q2 '26: -47M Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

Free Cash Flow TTM

-45M -30M -15M 0 15M 30M 45M Q2 '11: -18.8M Q3 '11: -19.6M Q4 '11: -20.3M Q2 '13: -41M Q3 '13: -38.3M Q4 '13: -36.2M Q1 '14: -27.1M Q2 '14: -22.5M Q3 '14: -18M Q4 '14: -17.4M Q1 '15: -22.3M Q2 '15: -2.8M Q3 '15: -5.7M Q4 '15: -721K Q2 '17: 3.7M Q2 '19: -15.3M Q3 '19: -15.4M Q4 '19: -15.3M Q1 '20: -14.8M Q2 '20: -13.2M Q3 '20: -14.4M Q4 '20: -13.5M Q2 '11 Q2 '13 Q1 '14 Q4 '14 Q3 '15 Q2 '19 Q1 '20 Q4 '20

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 35M 70M 105M Q2 '10: 6.5M Q3 '10: 6.5M Q2 '11: 9.7M Q3 '11: 10M Q3 '12: 14.6M Q2 '21: 7.4M Q3 '21: 9.5M Q1 '22: 9.5M Q2 '22: 9.6M Q3 '22: 9.7M Q1 '23: 17.9M Q2 '23: 19M Q3 '23: 21.1M Q1 '24: 25M Q2 '24: 34.3M Q3 '24: 34.4M Q1 '25: 34.7M Q2 '25: 34.7M Q3 '25: 51M Q1 '26: 53.4M Q2 '26: 93.5M Q2 '11 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-150.00 -100.00 -50.00 0.00 50.00 100.00 150.00 Q4 '11: -2.41 Q1 '12: -2.77 Q2 '12: -2.39 Q3 '12: -1.54 Q4 '12: -0.84 Q1 '13: -0.63 Q2 '13: -0.91 Q3 '13: -1.99 Q4 '13: -2.16 Q1 '14: -2.29 Q2 '14: -2.19 Q3 '14: -1.74 Q2 '15: -0.95 Q3 '15: -0.88 Q4 '15: -0.56 Q1 '16: -0.48 Q2 '16: -0.45 Q3 '16: -12.91 Q4 '16: -35.86 Q1 '17: -45.40 Q2 '17: -123.83 Q3 '17: -120.17 Q4 '17: -100.45 Q1 '18: -93.22 Q2 '18: -16.38 Q3 '18: -8.13 Q4 '18: -5.51 Q1 '19: -3.96 Q2 '19: -12.22 Q3 '19: -20.58 Q4 '19: -25.94 Q1 '20: -27.21 Q2 '20: -18.81 Q3 '20: -10.88 Q4 '20: -6.08 Q1 '21: -5.23 Q2 '21: -5.08 Q3 '21: -4.65 Q4 '21: -4.23 Q1 '22: -3.73 Q2 '22: -3.28 Q3 '22: -3.92 Q4 '22: -3.99 Q1 '23: -3.69 Q2 '23: -3.04 Q3 '23: -2.03 Q4 '23: -1.51 Q1 '24: -1.27 Q2 '24: -1.09 Q3 '24: -1.11 Q4 '24: -1.23 Q1 '25: -1.34 Q2 '25: -1.46 Q3 '25: -1.38 Q4 '25: -1.28 Q1 '26: -1.10 Q2 '26: -1.53 Q4 '11 Q4 '13 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.